Trials / Completed
CompletedNCT03193372
A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,200 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To survey rosacea patients about their concerns, treatment satisfaction, and quality of life associated with their Finacea Foam treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azelaic Acid (Finacea Foam, BAY39-6251) | Finacea Foam, Active substance Azelaic acid |
Timeline
- Start date
- 2017-07-20
- Primary completion
- 2017-08-08
- Completion
- 2017-11-15
- First posted
- 2017-06-20
- Last updated
- 2020-04-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03193372. Inclusion in this directory is not an endorsement.